Growing healthcare investments and rising cases of inflammation-related disorders have contributed to an expanding global demand for pharmaceuticals that support pain and symptom management. Diflunisal continues to serve a vital role in the broader anti-inflammatory drug landscape, supported by its established clinical history and safety profile. Healthcare providers in various regions rely on...